 |
|
Dipivefrin and Epinephrine Treatment of Elevated Intraocular PressureA Comparative Study
Michael A. Kass, MD;
Alan I. Mandell, MD;
Ivan Goldberg, FRACS;
J. Macon Paine;
Bernard Becker, MD
Arch Ophthalmol. 1979;97(10):1865-1866.
Abstract
• Every 12 hours 0.1% dipivefrin was administered to one eye and 2% epinephrine hydrochloride was administered to the fellow eye of 42 patients with primary open-angle glaucoma or ocular hypertension in a randomized, double-masked study lasting three months. Dipivefrin produced similar percent reductions in intraocular pressure (18.6%) to epinephrine (21.0%), as well as similar increases in outflow facility and pupil diameter. A significantly lower incidence of burning and stinging after drug instillation was noted with dipivefrin therapy. This study supported the contention that dipivefrin is an effective and safe alternative to epinephrine therapy for the reduction of elevated intraocular pressure.
Author Affiliations
From the Glaucoma Center, Department of Ophthalmology (Drs Kass, Goldberg, and Becker) and the Division of Biostatistics (Ms Paine), Washington University School of Medicine, St Louis, and the Department of Ophthalmology (Dr Mandell), University of Tennessee Center for the Health Sciences, Memphis.
Footnotes
Accepted for publication Jan 23, 1979.
Reprint requests to Glaucoma Center, Department of Ophthalmology, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110 (Dr Kass).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Apraclonidine: A One-Week Dose-Response Study
Jampel et al.
Arch Ophthalmol 1988;106:1069-1073.
ABSTRACT
Effects of Echothiophate on Enzymatic Hydrolysis of Dipivefrin
Anderson et al.
Arch Ophthalmol 1984;102:913-916.
ABSTRACT
|
